Abstract

Tertiary hyperparathyroidism (THPT) is characterized by persistent secondary hyperparathyroidism following successful kidney transplantation. In this case, there is an autonomous proliferation of the parathyroid glands and an over secretion of the parathyroid hormone, which is less likely to recover spontaneously. If untreated, this disease will affect patient survival and renal allograft. Classically in THPT; there is hyperplasia of all parathyroid glands; single or double adenomas are seen in 20% of patients. This review the features of THPT, its pathophysiology, the risk factors, complications and treatment options.

Keywords: Parathyroid gland · Parathyroid hormone · Tertiary hyperparathyroidism · Kidney transplantation

References

  1. 1.Bonarek H, Merville P, Bonarek M, Moreau K, Morel D, Aparicio M, et al. Reduced parathyroid functional mass after successful kidney transplantation. Kidney international. 1999;56(2):642-9.
  2. 2.Lewin E, Olgaard K. Parathyroidectomy vs calcimimetics for treatment of persistent hyperparathyroidism after kidney transplantation. Nephrology Dialysis Transplantation. 2006;21(7):1766-9.
  3. 3.Abouchacra S, Chaaban A, Baki AA, Al Mashari K, Al Sobhi S, Al Zahrani A, et al. Experience with Post Transplant Parathyroidectomy in Gulf Region and Literature Review. Open Journal of Nephrology. 2013;3(04):211.
  4. 4.Triponez F, Clark OH, Vanrenthergem Y, Evenepoel P. Surgical treatment of persistent hyperparathyroidism after renal transplantation. Annals of surgery. 2008;248(1):18-30. Majmaah Journal of Health Sciences ,Vol. 8, Issue 2, May - 2020 , Ramadan - 1441 145 Tertiary Hyperparathyroidism:ANarrative Mini-Review
  5. 5.Pitt SC, Sippel RS, Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. The Surgical clinics of North America. 2009;89(5):1227.
  6. 6.Cheng S-P, Lee J-J, Liu T-P, Yang T-L, Chen H-H, Wu C-J, et al. Parathyroidectomy improves symptomatology and quality of life in patients with secondary hyperparathyroidism. Surgery. 2014;155(2):320-8.
  7. 7.Tang JA, Friedman J, Hwang MS, Salapatas AM, Bonzelaar LB, Friedman M. Parathyroidectomy for tertiary hyperparathyroidism: Asystematic review.American journal of otolaryngology. 2017;38(5):630-5.
  8. 8.Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrology Dialysis Transplantation. 2004;19(5):1281-7.
  9. 9.Perrin P, Caillard S, Javier R, Braun L, Heibel F, Borni‐Duval C, et al. Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation. American Journal of Transplantation.2013;13(10):2653-63.
  10. 10.Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. Journal of theAmerican Society of Nephrology. 2002;13(2):551-8.
  11. 11.Evenepoel P, Claes K, Kuypers DR, Debruyne F, Vanrenterghem Y. Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrology Dialysis Transplantation. 2007;22(6):1730-7.
  12. 12.Hsieh T-M, Sun C-K, Chen Y-T, Chou F-F. Total parathyroidectomy versus subtotal parathyroidectomy in the treatment of tertiary hyperparathyroidism. The American Surgeon. 2012;78(5):600-6.
  13. 13.Madorin C, Owen RP, Fraser WD, Pellitteri PK, Radbill B, RinaldoA, et al. The surgicalmanagementofrenalhyperparathyroidism. European Archives of Oto-Rhino-Laryngology. 2012;269(6):1565-76.
  14. 14.Milas M, Weber CJ. Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism. Surgery. 2004;136(6):1252-60.
  15. 15.Alkhalili E, Tasci Y, Aksoy E, Aliyev S, Soundararajan S, Taskin E, et al. The utility of neck ultrasound and sestamibi scans in patients with secondary and tertiary hyperparathyroidism. World journal of surgery. 2015;39(3):701-5.
  16. 16.Karipineni F, Sahli Z, Somervell H, Mathur A, Prescott JD, Tufano RP, et al. Are preoperative sestamibi scans useful for identifying ectopic parathyroid glands in patients with expected multigland parathyroid disease? Surgery. 2018;163(1):35-41.
  17. 17.Cohen JB, Gordon CE, Balk EM, Francis JM. Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis. Transplantation. 2012;94(10):1041-8.
  18. 18.Dulfer R, Franssen G, Hesselink D, Hoorn E, van Eijck C, van GinhovenT. Systematic review of surgical and medical treatment for tertiary hyperparathyroidism. British Journal of Surgery. 2017;104(7):804-13.
  19. 19.Carrasco FR, Perez-Flores I, Calvo N, Ridao N, Sanchez A, Barrientos. Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure. Transplant Proc. 146 Majmaah Journal of Health Sciences ,Vol. 8, Issue 2, May - 2020 , Ramadan - 1441 Tertiary Hyperparathyroidism:ANarrative Mini-Review 2009;41(6):2385-7.
  20. 20.Courbebaisse M, Diet C, Timsit M-O, Mamzer M-F, Thervet E, Noel L-H, et al. Effects of cinacalcet in renal transplant patients with hyperparathyroidism. American journal of nephrology. 2012;35(4):341-8.
  21. 21.Yang RL, Freeman K, Reinke CE, Fraker DL, Karakousis GC, Kelz RR, et al. Tertiary hyperparathyroidism in kidney transplant recipients: characteristics of patients selected for different treatment strategies. Transplantation. 2012;94(1):70-6.
  22. 22.Torregrosa JV, Morales E, Diaz JM, Crespo J, Bravo J, Gomez G, et al. Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study. Nephrology (Carlton). 2014;19(2):84-93.
  23. 23.Dulfer RR, Koh EY, van der Plas WY, Engelsman AF, van Dijkum EJMN, Pol RA, et al. Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis. Langenbeck's Archives of Surgery. 2019;404(1):71-9.
  24. 24.Copley JB, Wüthrich RP. Therapeutic management of post‐kidney transplant hyperparathyroidism. Clinical transplantation. 2011;25(1):24-39.
  25. 25.Cruzado JM, Moreno P, Torregrosa JV, Taco O, Mast R, Gómez-Vaquero C, et al. A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. Journal of the American Society of Nephrology. 2016;27(8):2487-94.
  26. 26.Dewberry LC, Tata S, Graves S, Weber CJ, Sharma J. Predictors of tertiary hyperparathyroidism: Who will benefit from parathyroidectomy? Surgery. 2014;156(6):1631-7.
  27. 27.Finnerty BM, Chan TW, Jones G, Khader T, Moore M, Gray KD, et al. Parathyroidectomy versus Cinacalcet in the Management of Tertiary Hyperparathyroidism: surgery improves renal transplant allograft survival. Surgery. 2019;165(1):129-34.
  28. 28.Ohe MN, Santos RO, Kunii I, Carvalho A, Abrahão M, Cervantes O, et al. Usefulness of a rapid immunometric assay for intraoperative parathyroid hormone measurements. Brazilian Journal of Medical and Biological Research. 2003;36(6):715-21.
  29. 29.Schlosser K, Endres N, Celik I, Fendrich V, Rothmund M, Fernández ED. Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World journal of surgery. 2007;31(10):1947-53.
  30. 30.Gasparri G, Camandona M, Bertoldo U, Sargiotto A, Papotti M, Raggio E, et al. The usefulness of preoperative dual-phase 99mTc MIBI-scintigraphy and IO-PTH assay in the treatment of secondary and tertiary hyperparathyroidism. Annals of surgery. 2009;250(6):868-71.
  31. 31.Jäger MD, Kaaden S, Emmanouilidis N, Lück R, Beckmann JH, Güner Z, et al. Effect of incomplete parathyroidectomy preserving entire parathyroid glands on renal graft function. Archives of Surgery. 2011;146(6):704-10.
  32. 32.Yamamoto T, Tominaga Y, Okada M, Hiramitsu T, Tsujita M, Goto N, et al. Characteristics of Persistent Hyperparathyroidism After Renal Transplantation. World Journal of Surgery. 2016;40(3):600-6.
  33. 33.Triponez F, Kebebew E, Dosseh D, Duh Q-Y, Hazzan M, Noel C, et al. Less-than-subtotal parathyroidectomy increases the risk of Majmaah Journal of Health Sciences ,Vol. 8, Issue 2, May - 2020 , Ramadan - 1441 147 Tertiary Hyperparathyroidism:ANarrative Mini-Review persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. Surgery. 2006;140(6):990-9.
  34. 34.Somnay YR, Weinlander E, Alfhefdi A, Schneider D, Sippel RS, Chen H. Radioguided parathyroidectomy for tertiary hyperparathyroidism. Journal of Surgical Research. 2015;195(2):406-11.
  35. 35.Kebebew E, Duh Q-Y, Clark OH.Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy. Archives of Surgery. 2004;139(9):974-7.
  36. 36.van der Plas WY, Noltes ME, van Ginhoven TM, Kruijff S. Secondary and Tertiary Hyperparathyroidism: A Narrative Review. Scand J Surg. 2019:1457496919866015.
  37. 37.Lou I, Foley D, Odorico SK, Leverson G, Schneider DF, Sippel R, et al. How Well Does Renal Transplantation Cure Hyperparathyroidism? Ann Surg. 2015;262(4):653-9.
  38. 38.Torregrosa JV, Morales E, Díaz JM, Crespo J, Bravo J, Gómez G, et al. Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3‐year study. Nephrology. 2014;19(2):84-93.
  39. 39.Yang RL, Freeman K, Reinke CE, Fraker DL, Karakousis GC, Kelz RR, et al. Tertiary hyperparathyroidism in kidney transplant recipients: characteristics of patients selected for different treatment strategies. Transplantation. 2012;94(1):70-6.
  40. 40.Schwarz A, Merkel S, Leitolf H, Haller H. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism. Transplantation. 2011;91(5):560-5.
  41. 41.Henschkowski J, Bischoff-Ferrari HA, Wüthrich RP, Serra AL. Renal function in patients treated with cinacalcet for persistent hyperparathyroidism after kidney transplantation. Kidney and Blood Pressure Research. 2011;34(2):97-103.
  42. 42.DouthatWG, Cardozo G, Garay G, Orozco S, Chiurchiu C, de la Fuente J, et al. Use of percutaneous ethanol injection therapy for recurrent secondary hyperparathyroidism after subtotal parathyroidectomy. International journal of nephrology. 2011;2011. [43]YamamotoH,KatohN,TakeyamaH,Ikeda M, Yokoyama K, Shigematsu T, et al. Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients. Nephrology Dialysis Transplantation. 2003;18(suppl_3):iii50-iii2.

Peer review

Peer reviewed by 2 reviewers, who chose to remain anonymous.

Majmaah Journal of Health Sciences · eISSN 1658-8223 · Majmaah University · open access